Skip to main content
. 2020 May 6;52(4):1219–1228. doi: 10.4143/crt.2019.688

Table 1.

Detection rates for circulating tumor DNA (ctDNA)

Positive/Cases with somatic mutations
ctDNA: PIK3CA and/or KRAS ctDNA: PIK3CA ctDNA: KRAS
Epithelial ovarian carcinoma
 Total 23/85 (27.1) 11/40 (27.5) 12/48 (25.0)
 Stage I/II 13/66 (19.7) 7/32 (21.9) 6/37 (16.2)
 Stage III/IV 10/19 (52.6) 4/8 (50.0) 6/11 (54.5)
Borderline tumor 4/25 (16.0) 0/2 (0.0) 4/24 (16.7)
Benign tumor 0/4 (0.0) - 0/4 (0.0)

Values are presented as number (%).